Seno Medical Signs an Exclusive Distributor Agreement with Genetik for Imagio Breast Imaging System in Southeast Asia
Shots:
- The companies collaborated for Imagio Opto-Acoustic/Ultrasound (OA/US) breast imaging system to helps physicians differentiate between benign and malignant breast lesions
- The system uses a combination of noninvasive ultrasound and optoacoustic technology to provide information on breast lesions in real-time. It combines laser optics and grayscale ultrasound to provide fused functional and anatomical breast imaging
- The system has received the US FDA clearance in 2021 and received a supplemental PMA approval for its market-ready device in June 2022. The system will be a more effective tool to aid radiologists in confirming or excluding malignancy compared with traditional diagnostic imaging modalities and also includes the SenoGram AI decision-support tool
Ref: PRNewswire | Image: Lydus Medical
Related News:- Lydus Medical’s Vesseal Device Receives the US FDA’s Clearance for Small Arteries
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
